Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

21,455.00ZAc
3:41am EDT
Price Change (% chg)

-211.00c (-0.97%)
Prev Close
21,666.00c
Open
21,364.00c
Day's High
21,550.00c
Day's Low
21,200.00c
Volume
180,553
Avg. Vol
913,669
52-wk High
22,391.00c
52-wk Low
11,513.00c

APNJ.J

Chart for APNJ.J

About

Aspen Pharmacare Holdings Limited is a supplier of generic medicines in South Africa and Australia. The Company operates in South Africa, Mexico, Venezuela, Brazil, Ireland, Germany, Kenya, Tanzania, Uganda, United Arab Emirates, Mauritius, Hong Kong, Philippines and Australia. The Company has 18 manufacturing facilities at 13... (more)

Overall

Beta: 0.47
Market Cap (Mil.): R98,739.39
Shares Outstanding (Mil.): 455.73
Dividend: 157.00
Yield (%): 0.71

Financials

  APNJ.J Industry Sector
P/E (TTM): 32.31 34.93 35.13
EPS (TTM): 6.71 -- --
ROI: 12.23 19.47 18.83
ROE: 17.41 20.22 19.68
Search Stocks

BRIEF-Aspen Pharmacare says H1 headline earnings rise

JOHANNESBURG, March 7 - Aspen Pharmacare Holdings Ltd : * Says revenue from continuing operations increased 20% to R9,0 billion * Says operating profit from continuing operations increased 24% to R2,5

07 Mar 2013

BRIEF-Aspen Pharmacare says expects higher H1 earnings

JOHANNESBURG, Feb 21 - Aspen Pharmacare Holdings Ltd : * Says H1 headline earnings per share are expected to exceed those reported in

21 Feb 2013

BRIEF-Aspen says in talks to buy pharmaceutical ingredient facility in Netherlands

JOHANNESBURG, Feb 4 - Aspen Pharmacare Holdings Ltd : * Says Aspen is currently engaged in discussions with msd * Says talks in respect of possible acquisition of an active pharmaceutical

04 Feb 2013

South Africa's Aspen finalizes GSK deal for $263 million

JOHANNESBURG - South Africa's Aspen Pharmacare said on Monday it has finalized the acquisition of medicines from GlaxoSmithKline for 163.8 million pounds ($263 million).

03 Dec 2012

UPDATE 1-S.Africa awards $667 mln HIV drugs supply contract

JOHANNESBURG, Nov 29 - South Africa on Thursday awarded a $667 million contract to supply life-prolonging HIV medicine to 12 international and domestic firms, to deal with its biggest health problem.

29 Nov 2012

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: GlobalData
$250.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$472.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks